Clinical Trials
4 trialsNCT03871855 2023-06-05
A Study of SHR-1702 Alone or With Camrelizumab in Participants With Advanced Relapsed/Refractory Solid Tumors
Jiangsu HengRui Medicine Co., Ltd.
Phase 1 Terminated
NCT05809336 2023-04-12
Gut Microbial Metabolites Inosine Combined With PD-1/PD-L1 Inhibitor for Patients With Malignant Advanced Solid Tumors
Beijing Friendship Hospital
Phase 2/3 Completed
NCT05429398 2022-06-23
A Study of Linperlisib Combination With Camrelizumab in Patients With Solid Tumor
Shanghai YingLi Pharmaceutical Co. Ltd.
Phase 1 Unknown
NCT04282278 2021-12-10
Study of Anti-PD-1 Antibody Multimodal Combination as First-line Treatment on Time Window of Advanced Solid Tumor
Hebei Medical University Fourth Hospital
Phase 2 Unknown